Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2012
09/18/2012US8268319 Immunoconjugates with an intracellularly-cleavable linkage
09/18/2012US8268318 Polyalkylene oxides having hindered ester-based biodegradable linkers
09/18/2012US8268317 Camptothecin-binding moiety conjugates
09/18/2012US8268316 Monoclonal antibody specific to anthrax toxin
09/18/2012US8268315 Hepatocyte growth factor (HGF) binding proteins
09/18/2012US8268314 Bispecific anti-VEGF/anti-ANG-2 antibodies
09/18/2012US8268313 Methods for using inhibitors of vascular endothelial growth factor activity
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268311 Human GM-CSF antigen binding proteins
09/18/2012US8268310 Prevention and treatment of complement-associated eye conditions
09/18/2012US8268309 Compositions and methods for the therapy and diagnosis of cytomegalovirus
09/18/2012US8268308 Means for the diagnosis and therapy of CTCL
09/18/2012US8268307 Enhancing efficacy of vaccines administered via the respiratory tract
09/18/2012CA2769991A1 Met inhibitors for enhancing radiotherapy efficacy
09/18/2012CA2603414C Anti-cd20 monoclonal antibody
09/18/2012CA2598078C Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
09/18/2012CA2569554C Bacteriophages that infect bacillus bacteria (anthrax)
09/18/2012CA2529742C Composition of a vegf antagonist and an anti-proliferative agent
09/18/2012CA2523449C Recombinant antibodies and fragments which recognize n glycolil gm3 ganglioside and its use in diagnosis and treatment of tumours
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2445746C Chimeric immunoreceptor useful in treating human cancers
09/18/2012CA2424602C Antibody composition-producing cell
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2330313C Immunization against and treatment for infection by h.pylori
09/18/2012CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/18/2012CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122533A2 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
09/13/2012WO2012122524A1 Wound healant system and method of use
09/13/2012WO2012122514A1 Extracellular targeted drug conjugates
09/13/2012WO2012122513A2 Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution
09/13/2012WO2012122396A1 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
09/13/2012WO2012122383A2 Pi3 kinase inhibitors and uses thereof
09/13/2012WO2012122361A2 System and method of cooling a pump head used in chromatography
09/13/2012WO2012122343A2 Polyhydroxyalkanoate production method
09/13/2012WO2012122030A2 Oral bacteria and uses thereof
09/13/2012WO2012121958A2 Combination
09/13/2012WO2012121754A1 Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
09/13/2012WO2012121679A1 Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage
09/13/2012WO2012121529A2 Composition for nerve-cell or endothelial-cell regeneration comprising a ninjurin action suppressing agent
09/13/2012WO2012121528A2 Magnetic nanocomposite specific for thyroid cancer and use thereof
09/13/2012WO2012121403A1 The method of treating amyotrophic lateral sclerosis
09/13/2012WO2012120518A1 Compositions and methods for diagnosing and treating phenylketonuria (pku)
09/13/2012WO2012120131A1 Methods for generating cell microparticles
09/13/2012WO2012120128A1 Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
09/13/2012WO2012120124A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/13/2012WO2012120035A1 Anti oligomer antibodies and uses thereof
09/13/2012WO2012119972A1 Conjugation process
09/13/2012WO2012119769A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccine
09/13/2012WO2012119326A1 Method for preparing branched polypepdides
09/13/2012WO2012103444A3 Immunogenic compositions and reagents for preparing
09/13/2012WO2012095432A3 Tlr3 binding agents
09/13/2012WO2012093406A3 A combination heptavalent vaccine
09/13/2012WO2012089833A3 Expression systems
09/13/2012WO2012087962A3 Anti-mesothelin antibodies and immunoconjugates
09/13/2012WO2012082470A3 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer
09/13/2012WO2012078633A8 Methods of inhibiting metastasis from cancer
09/13/2012WO2012074881A3 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
09/13/2012WO2012073047A3 Compositions and methods
09/13/2012WO2012071521A3 Adjuvant
09/13/2012WO2012061910A3 Main immunoprotective domains and epitopes of nucleoside hydrolase from leishmania (l) donovani for use in vaccination, immunotherapy and diagnosis
09/13/2012WO2012048817A3 Recombinant modified vaccinia virus ankara (mva) influenza vaccine
09/13/2012WO2011088120A8 Antibody formulation and therapeutic regimens
09/13/2012US20120232022 Botulinum toxin treatments
09/13/2012US20120231086 Protein matrix vaccines of improved immunogenicity
09/13/2012US20120231041 Immunomodulating Nanoparticulate Composition
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120231035 Method for inducing cell lysis with immunogenic portions of ny-eso-1 protein
09/13/2012US20120231034 Use of botulinum neurotoxin to treat substance addictions
09/13/2012US20120231033 Inactivated poultry vaccine
09/13/2012US20120231030 Multi-epitopic vaccine
09/13/2012US20120231029 Enhanced malaria msp-1 subunit vaccine
09/13/2012US20120231028 Polyvalent vaccine
09/13/2012US20120231027 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
09/13/2012US20120231026 Methods and compositions for tumor vaccination and therapy
09/13/2012US20120231025 Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions
09/13/2012US20120231024 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer
09/13/2012US20120231023 Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells
09/13/2012US20120231021 Antibodies specifically binding to the epidermal growth factor receptor
09/13/2012US20120231020 Markers for selecting personalized therapies for the treatment of cancer
09/13/2012US20120231019 Fibrosis inhibitor
09/13/2012US20120231018 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231016 Pharmaceutical Composition for Inhibiting Histone H4 and Manufacturing Method Thereof
09/13/2012US20120231015 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto
09/13/2012US20120231014 Neural Regeneration
09/13/2012US20120231013 Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods
09/13/2012US20120231012 Diagnosis, treatment, and prevention of vascular disorders using interleukin-1 autoantibodies
09/13/2012US20120231011 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody
09/13/2012US20120231010 Vinpocetine and eburn amonine derivatives for promoting bone growth
09/13/2012US20120231009 Formulations of Antibody
09/13/2012US20120231008 Anti-C5A Binding Moieties with High Blocking Activity
09/13/2012US20120231007 Modulators of cell cycle progression
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120231005 Ax1 and ax189 psck9 antagonists and variants
09/13/2012US20120231004 Antibodies
09/13/2012US20120231003 Ox2 Receptor Homologs
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 1823